• Text size
  • Send this article to a friend
  • Print this article

NHS body's guidance on Alzheimer's drug is criticised

The Appeal Court in London ruled yesterday that an NHS advisory body should have been more transparent in the way it made decisions over Alzheimer's drugs.

The Appeal Court in London ruled yesterday that an NHS advisory body should have been more transparent in the way it made decisions over Alzheimer's drugs.